JPH01136663A - Manufacture of antibacterial molded item - Google Patents
Manufacture of antibacterial molded itemInfo
- Publication number
- JPH01136663A JPH01136663A JP62296755A JP29675587A JPH01136663A JP H01136663 A JPH01136663 A JP H01136663A JP 62296755 A JP62296755 A JP 62296755A JP 29675587 A JP29675587 A JP 29675587A JP H01136663 A JPH01136663 A JP H01136663A
- Authority
- JP
- Japan
- Prior art keywords
- silver
- latex
- agent
- cationic
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 229920000126 latex Polymers 0.000 claims abstract description 44
- 239000004816 latex Substances 0.000 claims abstract description 43
- 229940100890 silver compound Drugs 0.000 claims abstract description 19
- 150000003379 silver compounds Chemical class 0.000 claims abstract description 19
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 125000002091 cationic group Chemical group 0.000 claims abstract description 13
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 9
- 101000868789 Drosophila melanogaster Carboxypeptidase D Proteins 0.000 claims abstract description 5
- 238000000576 coating method Methods 0.000 claims description 23
- 229920006173 natural rubber latex Polymers 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- 239000011248 coating agent Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 229920006174 synthetic rubber latex Polymers 0.000 claims description 9
- 238000000034 method Methods 0.000 abstract description 35
- 239000000178 monomer Substances 0.000 abstract description 13
- 229910052709 silver Inorganic materials 0.000 abstract description 11
- 239000004332 silver Substances 0.000 abstract description 11
- 229920001577 copolymer Polymers 0.000 abstract description 10
- 238000007598 dipping method Methods 0.000 abstract description 10
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract description 8
- 229920002554 vinyl polymer Polymers 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 239000003242 anti bacterial agent Substances 0.000 abstract description 5
- 239000000945 filler Substances 0.000 abstract description 4
- 150000003378 silver Chemical class 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 238000004073 vulcanization Methods 0.000 abstract description 3
- 239000004902 Softening Agent Substances 0.000 abstract description 2
- 239000003086 colorant Substances 0.000 abstract description 2
- 239000006185 dispersion Substances 0.000 abstract description 2
- 239000002612 dispersion medium Substances 0.000 abstract description 2
- 238000004070 electrodeposition Methods 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 abstract description 2
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 abstract description 2
- 229920001206 natural gum Polymers 0.000 abstract 2
- 239000000701 coagulant Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 9
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000005060 rubber Substances 0.000 description 8
- 238000007654 immersion Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 238000000465 moulding Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 244000043261 Hevea brasiliensis Species 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 150000001993 dienes Chemical class 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 229920003052 natural elastomer Polymers 0.000 description 3
- 229920001194 natural rubber Polymers 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000004018 acid anhydride group Chemical group 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- XMYQHJDBLRZMLW-UHFFFAOYSA-N methanolamine Chemical group NCO XMYQHJDBLRZMLW-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- TYTYIUANSACAEM-UHFFFAOYSA-M silver;2,4,6-trinitrophenolate Chemical compound [Ag+].[O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O TYTYIUANSACAEM-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000286663 Ficus elastica Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- -1 for example Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011817 metal compound particle Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- SDLBJIZEEMKQKY-UHFFFAOYSA-M silver chlorate Chemical compound [Ag+].[O-]Cl(=O)=O SDLBJIZEEMKQKY-UHFFFAOYSA-M 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、コーティング法にて成型品を製造する方法に
関するものであり、さらに詳しくは、コーティング法に
て抗菌性能を有する成型品を製造する方法に関するもの
である。[Detailed Description of the Invention] (Industrial Application Field) The present invention relates to a method for manufacturing a molded product by a coating method, and more specifically, a method for manufacturing a molded product having antibacterial properties by a coating method. It is about the method.
(従来の技術)
浸漬法などのコーティング法によってゴム製品を製造す
る際に用いられる原料ラテックスとしては1例えば、天
然ゴムラテックス、クロロプレンラテックス、ブタジェ
ン−スチレン共重合体ラテックスなどがあげられる。(Prior Art) Examples of raw latexes used when manufacturing rubber products by coating methods such as dipping methods include natural rubber latex, chloroprene latex, and butadiene-styrene copolymer latex.
天然ゴムラテックスは、ゴム樹に切付けを行った時に流
れでる乳白色の樹液に1通常保存剤として主としてアン
モニアを0.3〜1.0%添加したものであり、このラ
テックスの組成はゴム分炭化水素を35〜40%含む以
外に、約2%のタンパク質、その他1%以下の少量の脂
肪酸又はそのエステル、ステロール、複合脂質、糖類、
無機質、酵素などからなる。したがって、天然ゴムラテ
ックスにおいては、その成分中に含まれる両性電解質で
あるタンパク質がゴム粒子の表面に吸着することにより
一種の保護コロイド的な役割を果たして。Natural rubber latex is made by adding 0.3 to 1.0% of ammonia as a normal preservative to the milky white sap that flows out when a rubber tree is cut.The composition of this latex is that of rubber carbonization. In addition to containing 35-40% hydrogen, it also contains about 2% protein, other small amounts of less than 1% fatty acids or their esters, sterols, complex lipids, sugars,
Consists of minerals, enzymes, etc. Therefore, in natural rubber latex, the amphoteric electrolyte protein contained in its components plays a role like a kind of protective colloid by adsorbing to the surface of rubber particles.
ラテックス粒子の安定なる浮遊分散を助けている。″す
なわち、これらゴム粒子は弱酸性及びアルカ1ノ性領域
では蝋荷を有するところから、ゴム粒子間に静電気的な
反撥力を生じ凝集することなく安定に分散している。ゴ
ム樹から流れ出した新鮮なラテックスは、はとんど中性
(pH7,0〜7.2)の比較的不安定なエマルジョン
である。すなわち、熱帯地方ではラテックスを空気に曝
すとバクテリアの作用で急速に酸敗し、12〜14時間
でpHは5程度となり、自然凝固を起こす。これはラテ
ックス水相中にタンパク質や塩類、糖類などのようなバ
クテリアの繁殖には極めて好都合な物質が含まれている
ため、バクテリアが極めて急速に繁殖する□ためである
。それ故、なるべく酸敗の進まない早い時期に適当な保
存剤を加える必要があるが。Helps stabilize floating dispersion of latex particles. ``In other words, since these rubber particles have a wax charge in the weakly acidic and alkaline regions, electrostatic repulsion occurs between the rubber particles and they are stably dispersed without agglomeration. Fresh latex is mostly a neutral (pH 7.0-7.2) and relatively unstable emulsion; that is, in tropical regions, when latex is exposed to air, it quickly turns rancid due to the action of bacteria; After 12 to 14 hours, the pH will reach about 5 and spontaneous coagulation will occur.This is because the latex aqueous phase contains substances that are extremely favorable for bacterial growth, such as proteins, salts, and sugars. This is because they reproduce extremely rapidly.Therefore, it is necessary to add an appropriate preservative as early as possible before rancidity progresses.
葆存剤としては酸を中和し、かつバクテリアを撃退して
その繁殖を防止する上でアンモニアが最も好適とされて
いる。アンモニアは通常0.3〜1.0%添加されるた
め、ラテックスのpHは少なくとも9以上1通常は10
以上のアルカリ性に保たれている。現在、天然ゴムラテ
ックスの日本工業規格として制寓されているJIS K
638H1982)はこの線に沿って制定されたもの
である。Ammonia is considered to be the most suitable preservative because it neutralizes acids and repels bacteria to prevent their proliferation. Since ammonia is usually added in an amount of 0.3 to 1.0%, the pH of the latex is at least 9 or higher, usually 10.
It is maintained at an alkaline level. JIS K is currently regulated as the Japanese Industrial Standard for natural rubber latex.
638H1982) was established along this line.
通常、コーティング法に用いられる配合ラテックスとは
、上記のごと゛き原料ラテックスに、必要に応じて加硫
剤、加硫促進剤、充填剤、軟化剤。Usually, the compound latex used in the coating method is the raw material latex as described above, and if necessary, a vulcanizing agent, a vulcanization accelerator, a filler, and a softening agent.
老化防止剤、 pH調整剤などを適宜配合したものであ
り、これらは配合後もアルカリ性に保たれているかある
いは保つべく調整されている。したがって現在1通常用
いられている天然ゴムラテックスは負に帯電したアニオ
ン系ラテックスをベースとしたものであり、各種コーテ
ィング成型製品は殆ど全てがこれらから製造されたもの
である。It contains anti-aging agents, pH adjusters, etc. as appropriate, and these are maintained or adjusted to remain alkaline even after being blended. Therefore, the natural rubber latex commonly used at present is based on negatively charged anionic latex, and almost all of the various coated molded products are manufactured from these.
また2合成ゴムラテックスとしては2例えば。2 Examples of synthetic rubber latex include 2.
ビニル系モノマーの単一重合体又はその共重合体。A homopolymer of vinyl monomers or a copolymer thereof.
ジエン系モノマーの単一重合体あるいはその共重合体、
上記ビニル系モノマーとジエン系モノマーの共重合体、
その他官能基としてエポキシド基。Single polymer of diene monomer or its copolymer,
A copolymer of the above vinyl monomer and diene monomer,
Other functional groups include epoxide groups.
アミン基、カルボキシル基、酸無水物基、水酸基。Amine group, carboxyl group, acid anhydride group, hydroxyl group.
アミド基、N−メチロールアミド基、イソシアネ一ト基
などを有するビニル系モノマーと上記各種モノマーとの
共重合体などを主成分としたものがあげられる。Examples include those whose main component is a copolymer of a vinyl monomer having an amide group, an N-methylolamide group, an isocyanate group, etc., and the various monomers mentioned above.
ラテックスの成型方法には1例えば、浸漬法などのコー
ティング法、キャスト法、押出法、フオームラバー製造
法、繊維表面加工法、繊維粘着法などがあるが、浸漬成
型法の場合には、その性格上、以下に述べるような特殊
な製造技術上の問題点がある。すなわち、浸漬成型法で
は浸漬槽にラテックスを満たし、その中に浸漬型を浸漬
し、その後引き上げることにより浸漬型にラテックスを
付着させるという製造方法をとるところから、実際に成
型品として消費されるラテックスに比し浸漬槽中に貯留
しているラテックスの方が圧倒的に多いために、浸漬槽
中でラテックスがゲル化した場合の経済的損失ははかり
知れないものがある。Latex molding methods include coating methods such as dipping methods, casting methods, extrusion methods, foam rubber manufacturing methods, fiber surface processing methods, and fiber adhesion methods. In addition, there are special manufacturing technology problems as described below. In other words, the immersion molding method involves filling a dipping tank with latex, immersing the immersion mold in it, and then pulling it up to adhere the latex to the immersion mold. Since the amount of latex stored in the dipping tank is overwhelmingly larger than that in the dipping tank, the economic loss when the latex gels in the dipping tank is immeasurable.
従来より、医療用具に持続的な抗菌活性を賦与する最も
有効な方法としては、その使用過程において一定濃度以
上の抗菌剤を基材中又は基材表面に保持させるよう抗菌
剤を分散させた。いわゆる=5=
マトリックスデバイスがシステムとして考えられている
。Conventionally, the most effective method for imparting sustained antibacterial activity to medical devices has been to disperse antibacterial agents so that a certain concentration or higher of the antibacterial agent is retained in or on the surface of the substrate during the course of its use. The so-called =5= matrix device is considered as a system.
他方、金、銀、銅、亜鉛などの重金属ならびにこれらの
金属化合物は、各々金属イオンの状態において極めて微
量の濃度で細菌、真菌などの微生物に対して強い殺菌効
果を持つことが知られており、オリゴダイナミーと呼ば
れている。On the other hand, heavy metals such as gold, silver, copper, and zinc, as well as their metal compounds, are known to have strong bactericidal effects against microorganisms such as bacteria and fungi at extremely small concentrations in the form of metal ions. , is called oligodynamism.
一般に銀化合物及び銀塩の水に対する溶解度が低いため
に、溶液状態でラテックスに配合したときは基材中の銀
濃度が非常に低くなる。また、基材中の銀濃度を高くす
るために1例えば、水溶解度の高い硝酸銀などを水溶液
にしてラテックスに添加した場合には、その理由は明ら
かではないが。Generally, silver compounds and silver salts have low solubility in water, so when they are blended into latex in a solution state, the silver concentration in the base material becomes very low. Furthermore, in order to increase the silver concentration in the base material, for example, silver nitrate, which has high water solubility, is added to the latex in the form of an aqueous solution, although the reason for this is not clear.
ラテックスが水溶液中に安定に浮遊している系を破壊せ
しめ、凝集が生じ、安定したラテックス組成物を得るこ
とができない。This destroys the system in which latex is stably suspended in an aqueous solution and causes aggregation, making it impossible to obtain a stable latex composition.
以上述べたような観点から、上記金属、とくに銀化合物
の持つオリゴダイナミーを利用し9基材上に金属体を被
着させたもの、あるいは基材中に金属を分散、配合した
用具が提案されている。From the above-mentioned viewpoints, tools have been proposed that make use of the oligodynamism of the above metals, especially silver compounds, and have a metal body adhered to a base material, or that have metals dispersed or blended in the base material. has been done.
例えば、特開昭52−62996号公報には。For example, in Japanese Patent Application Laid-Open No. 52-62996.
可撓性管体の表面にオリゴダイナミーを有する金属体、
あるいは金属体からなるリング、ネットなどを被着させ
たカテーテルが提案されている。しかし、成型されたカ
テーテルの表面に金属体を被着する操作は非常に面倒で
複雑であり、実製造現場における生産効率は低い。a metal body having oligodynamics on the surface of a flexible tube;
Alternatively, a catheter covered with a ring, net, etc. made of a metal body has been proposed. However, the operation of attaching a metal body to the surface of a molded catheter is extremely troublesome and complicated, and the production efficiency in actual manufacturing sites is low.
また、特開昭59−218517号公報には。Also, in JP-A-59-218517.
抗微生物性金属化合物を30μ以内の粒子に粉砕後、カ
テーテルを形成し得る懸濁剤中に分散し。The antimicrobial metal compound is ground into particles within 30 microns and then dispersed in a suspension capable of forming a catheter.
硬化させて抗微生物活性を有するカテーテルを形成する
方法が記載されている。しかしながら、金属化合物を3
0μ以内の粒子にする粉砕する工程及び粉砕した金属化
合物の粒子の再凝集を防ぎ。A method of curing to form a catheter with antimicrobial activity is described. However, 3 metal compounds
Prevents the pulverization process into particles with a size of 0μ or less and the re-agglomeration of the pulverized metal compound particles.
安定した粒子状態を保つために、いわゆる界面活性剤な
どの添加がひ必要であり、生産コストの上昇となる。In order to maintain a stable particle state, it is necessary to add a so-called surfactant, which increases production costs.
このように、オリゴダイナミーを利用して、それ自体が
抗菌性能を有するタイプの成型品を製造するには、上記
したように成型品を成型後、その表面に金属体を被着さ
せる工程又は金属化合物を微小な粒子に粉砕し、懸濁液
中に分散する工程が必要であり、これらは生産効率が低
(、また製造におけるコスト上昇となり2問題点となっ
ている。In this way, in order to produce a molded product that itself has antibacterial properties using oligodynamism, the process of applying a metal body to the surface of the molded product after molding as described above or A process of pulverizing the metal compound into fine particles and dispersing it into a suspension is required, which results in two problems: low production efficiency (and increased production costs).
(発明が解決しようとする問題点)
本発明の目的は、成型品自体が持続的な抗菌活性を有す
る抗菌性成型品の製造方法を提供することにある。(Problems to be Solved by the Invention) An object of the present invention is to provide a method for producing an antibacterial molded product in which the molded product itself has continuous antibacterial activity.
また1本発明の他の目的は、簡単な操作で、工業的に生
産性良く抗菌性成型品を製造する方法を提供することに
ある。Another object of the present invention is to provide a method for manufacturing antibacterial molded products industrially and with high productivity using simple operations.
また1本発明の他の目的は、銀化合物を含有するラテッ
クス組成物からなるコーティング液を用いて抗菌性成型
品を安定に製造する方法を提供することにある。Another object of the present invention is to provide a method for stably producing antibacterial molded articles using a coating liquid made of a latex composition containing a silver compound.
(問題点を解決するための手段)
本発明者らは、上記のごとき目的を達成すべく鋭意研究
を重ねた結果、カチオン系天然ゴムラテックス又はカチ
オン系合成ゴムラテックスに水溶性銀化合物を配合する
ことにより、安定性に優れたラテックス組成物が得られ
、コーティング液としてこの組成物を用いることによっ
て所期の目的を達成しうろことを見い出し1本発明に到
達した。(Means for Solving the Problems) As a result of extensive research in order to achieve the above objectives, the inventors of the present invention have blended a water-soluble silver compound into cationic natural rubber latex or cationic synthetic rubber latex. As a result, a latex composition with excellent stability can be obtained, and the inventors have discovered that the intended purpose can be achieved by using this composition as a coating liquid, and have thus arrived at the present invention.
すなわち2本発明は、天然ゴムラテックス又は合成ゴム
ラテックスからなるコーティング液を用い、コーティン
グ法にて成型品を製造するに際し。That is, the present invention is directed to manufacturing a molded product by a coating method using a coating liquid made of natural rubber latex or synthetic rubber latex.
コーティング液としてカチオン系天然ゴムラテックス又
はカチオン系合成ゴムラテックスに水溶性銀化合物を配
合したラテックス組成物を用いることを特徴とする抗菌
性成型品の製造方法を要旨とするものである。The gist of the present invention is a method for producing an antibacterial molded article, which is characterized in that a latex composition in which a water-soluble silver compound is blended with a cationic natural rubber latex or a cationic synthetic rubber latex is used as a coating liquid.
本発明にいう天然ゴムラテックスとは、ゴム植物の樹皮
に切付を行った時に流れ出る種々の有機物及び無機物を
含有した水溶液を分散媒体とし。The natural rubber latex referred to in the present invention is an aqueous solution containing various organic and inorganic substances that flows out when cutting the bark of a rubber plant as a dispersion medium.
ゴム分を分散質とし、必要に応じてpH8m整剤m抽剤
剤、加硫促進剤、軟化剤、充填剤、老化防止剤。The rubber component is used as a dispersoid, and if necessary, a pH 8m adjustment agent, extraction agent, vulcanization accelerator, softener, filler, and anti-aging agent.
着色剤などを配合したラテックスである。通常のラテッ
クスは、pHm1!整剤としてのアンモニアを0゜3重
量%含み、 pIIが9〜11に調整されたアニオン系
ラテックスである。これに対し本発明に用いられるカチ
オン系天然ゴムラテックスは、 pHが保護コロイドで
あるタンパク質の等電点であるpi+4.7以下、好ま
しくは3以下の、いわゆる酸性ラテックスがあげられ、
このものは、その状態ではゴム粒子は通常の天然ゴムラ
テックスとは逆の正電荷を帯びて互いに反撥することに
より安定化している。このような酸性ラテックスを調製
するには1例えば1通常の天然ゴムラテックス(固形分
濃度50〜60%、pH9〜11)に対し、カチオン系
界面活性剤又はノニオン系界面活性剤をゴム分に対して
1〜5重量%程度になるように加え。It is latex mixed with coloring agents. Normal latex has a pH of 1! It is an anionic latex containing 0.3% by weight of ammonia as a conditioner and has a pII adjusted to 9-11. On the other hand, the cationic natural rubber latex used in the present invention is a so-called acidic latex having a pH of pi+4.7 or less, which is the isoelectric point of the protein which is a protective colloid, and preferably 3 or less.
In this state, the rubber particles have a positive charge opposite to that of normal natural rubber latex and are stabilized by repelling each other. To prepare such an acidic latex, 1. For example, 1. Add a cationic surfactant or a nonionic surfactant to the rubber content of normal natural rubber latex (solid content concentration 50-60%, pH 9-11). Add so that the amount is about 1 to 5% by weight.
次に適当な無機酸又は有機酸を加えてpHを3以下にす
ればよい。無機酸としては塩酸、硫酸が、有機酸として
は蟻酸、酢酸、蓚酸などが好ましく用いられる。Next, a suitable inorganic or organic acid may be added to adjust the pH to 3 or less. Hydrochloric acid and sulfuric acid are preferably used as inorganic acids, and formic acid, acetic acid, oxalic acid and the like are preferably used as organic acids.
また2本発明に用いられるカチオン系合成ゴムラテック
スとしては2例えば、エチレン、スヂレン、 lt[ビ
ニル、塩化ビニル、塩化ビニリデン。Examples of the cationic synthetic rubber latex used in the present invention include ethylene, styrene, vinyl, vinyl chloride, and vinylidene chloride.
アクリロニトリル、 (メタ)アクリル酸エステル。Acrylonitrile, (meth)acrylic acid ester.
ビニルピリジン、メチルビニルエーテルなどのビニル系
モノマーの単一重合体又はその共重合体。A homopolymer of vinyl monomers such as vinyl pyridine and methyl vinyl ether, or a copolymer thereof.
ブタジェン、イソプレン、1.3−ペンタジェン。Butadiene, isoprene, 1,3-pentadiene.
1.5−へキサジエン、1,6−へブタジェン、クロロ
プレンなどのジエン系モノマーの単一重合体あるいはそ
の共重合体、上記ビニル系モノマーとジエン系モノマー
の共重合体、その他官能基としてエポキシド基、アミノ
基、カルボキシル基、酸無水物基、水酸基、アミド基、
N−メチロールアミド基、イソシアネート基などを有す
るビニル系モノマーと上記各種モノマーとの共重合体な
どを主成分とし、これに乳化分散剤としてカチオン系界
面活性剤を配合したものがあげられ、必要に応じてノニ
オン系界面活性剤、架橋剤、充填剤、軟化剤などを配合
したものがあげられる。A homopolymer of diene monomers such as 1,5-hexadiene, 1,6-hebutadiene, and chloroprene, or a copolymer thereof, a copolymer of the above-mentioned vinyl monomer and diene monomer, and other functional groups such as epoxide groups, Amino group, carboxyl group, acid anhydride group, hydroxyl group, amide group,
Examples include copolymers of vinyl monomers having N-methylolamide groups, isocyanate groups, etc., and the various monomers listed above, which are blended with cationic surfactants as emulsifying and dispersing agents. Depending on the situation, nonionic surfactants, crosslinking agents, fillers, softeners, etc. may be added.
本発明においては、抗菌剤として水溶性銀化合物を用い
る。好適な水溶性銀化合物としては、銀塩及びプロティ
ン銀があげられる。銀塩とは、銀と、無機酸又は有機酸
とで形成される塩を意味する。銀塩の好適な具体例とし
ては、硝酸銀、乳酸銀、塩素酸銀、フッ化銀、ピクリン
酸銀などかあげられる。プロティン銀とは、タンパク質
と銀との化合物であり1日本薬局方に収載されている銀
として7.5〜8.5重量%含むものが好ましく用いら
れる。In the present invention, a water-soluble silver compound is used as an antibacterial agent. Suitable water-soluble silver compounds include silver salts and protein silver. Silver salt means a salt formed between silver and an inorganic or organic acid. Preferred specific examples of silver salts include silver nitrate, silver lactate, silver chlorate, silver fluoride, and silver picrate. Protein silver is a compound of protein and silver, and preferably contains 7.5 to 8.5% by weight of silver listed in the Japanese Pharmacopoeia.
本発明にいう水溶性とは、20℃における100gの蒸
溜水に対する溶解度が1.0g以上、好ましくは5.0
8以上のものを意味する。Water solubility in the present invention means that the solubility in 100 g of distilled water at 20°C is 1.0 g or more, preferably 5.0 g.
It means 8 or more.
水溶性銀化合物の好ましい配合量は、その目的及び使用
する銀化合物の種類により異なるが、−船釣には、ラテ
ックスの固形分に対し、銀として0.1〜30重量%、
とくに0.5〜10重量%であることが好ましい。配合
量が30重量%を越える場合は、それから得られる成型
品の強度が劣る傾向にあり、一方、0.1重量%未満の
場合は抗菌性能が発揮しにくくなるので好ましくない。The preferred amount of the water-soluble silver compound varies depending on the purpose and the type of silver compound used, but for boat fishing, 0.1 to 30% by weight of silver based on the solid content of latex
In particular, it is preferably 0.5 to 10% by weight. When the amount is more than 30% by weight, the strength of the molded product obtained therefrom tends to be poor, while when it is less than 0.1% by weight, antibacterial performance becomes difficult to exhibit, which is not preferable.
本発明においてコーティング液を調製する方法は、各成
分が均一に混合される方法であれば特に限定されず、公
知の種々の方法を利用することができる。例えば、水溶
性銀化合物の水溶液、とくに好ましくは水溶性銀化合物
濃度の高い水溶液を直接ラテックス中に添加するなどの
方法が好ましく採用される。The method for preparing the coating liquid in the present invention is not particularly limited as long as each component is mixed uniformly, and various known methods can be used. For example, a method is preferably employed in which an aqueous solution of a water-soluble silver compound, particularly preferably an aqueous solution with a high concentration of a water-soluble silver compound, is directly added to the latex.
本発明の方法により成型品を製造するには、従来公知の
いかなる方法によってもよい。例えば。Any conventionally known method may be used to produce a molded article by the method of the present invention. for example.
浸漬法については、ストレート法、凝着浸漬法(アノー
ド法又はティーグ凝着法)、感熱浸漬法。The immersion methods include the straight method, adhesive immersion method (anodic method or Teague adhesive method), and thermal immersion method.
電着浸漬法などをあげることができる。具体例として、
天然ゴムを素材とする導尿カテーテルを製造する場合は
、導尿カテーテルが通常天然ゴムラテックスからコーテ
ィング法の−っである浸漬成形法によって作られるため
、コーティング液として上記水溶液銀化合物を配合した
天然ゴムラテックス組成物を特別に調製することにより
、従来と全く同じ製造法で製造することができる。また
。Examples include electrodeposition immersion method. As a specific example,
When manufacturing urinary catheters made of natural rubber, since urinary catheters are usually made from natural rubber latex by dip molding, which is a coating method, natural rubber containing the above-mentioned aqueous silver compound is used as the coating liquid. By specially preparing the rubber latex composition, it can be manufactured using exactly the same manufacturing method as conventional methods. Also.
コーティング液としてその他の合成ゴムラテックス組成
物を用いるときにも同様にして同種の基材又は異種の基
材からなる半製品をコーティング液に浸漬するか又は半
製品にコーティング液をスプレーする。いわゆるコーテ
ィング法によって製造することができる。When using other synthetic rubber latex compositions as the coating liquid, similarly, a semi-finished product made of the same type of base material or a different type of base material is immersed in the coating liquid, or the coating liquid is sprayed onto the semi-finished product. It can be manufactured by a so-called coating method.
(実施例)
以下、実施例をあげて本発明をさらに具体的に説明する
。(Examples) Hereinafter, the present invention will be explained in more detail by giving examples.
なお2例中の「部」は1重量部」を意味する。Note that "part" in the two examples means "1 part by weight."
実施例1
固型分濃度が約60重量%の酸性天然ゴムラテックス(
pH2,8)100部に、ジメチルジチオカルバミン酸
亜鉛0.4部、硫黄1部、亜鉛華2.5部及びステアリ
ン酸1部を均一に分散させて、天然ゴムを主成分とする
配合ラテックス(以下、A液という。)を調製した。上
記A液100部に。Example 1 Acidic natural rubber latex with a solid content concentration of about 60% by weight (
0.4 parts of zinc dimethyldithiocarbamate, 1 part of sulfur, 2.5 parts of zinc white, and 1 part of stearic acid are uniformly dispersed in 100 parts of pH 2.8) to create a blended latex (hereinafter referred to as , referred to as Solution A) was prepared. Add to 100 parts of the above solution A.
硝酸銀水溶液(10重量%)10部を攪拌上添加したと
ころ、ラテックスは凝集することなく、硝酸銀が均一に
分散したコーティング液(銀1.1重景%)を得ること
ができた。When 10 parts of a silver nitrate aqueous solution (10% by weight) was added with stirring, the latex did not coagulate, and a coating liquid (silver 1.1wt%) in which silver nitrate was uniformly dispersed could be obtained.
得られたコーティング液を用いて2通常の浸漬成型法に
よる導尿カテーテルの製造装置でその日の減量分を補充
するかたちで、工業的規模による連続生産を行ったとこ
ろ1力月後においても浸漬槽中のラテックスは凝集塊を
生しることなく、−定品質の導尿カテーテルを安定して
製造することができた。Using the obtained coating liquid, we carried out continuous production on an industrial scale by replenishing the amount lost on the day in a urinary catheter manufacturing device using the normal dip molding method. The latex contained therein did not form any agglomerates, and a urinary catheter of constant quality could be stably manufactured.
得られた導尿カテーテルについて、以下の方法により、
抗菌活性テスI・を行った。Regarding the obtained urinary catheter, the following method was used:
Antibacterial activity test I.
すなわち、得られた導尿カテーテルを切断し。That is, cut the resulting urinary catheter.
その切片を無菌環境下で70%エタノール水溶液で洗浄
し、エタノールを乾燥、留去した後、サンプル瓶の底に
内表面が上を向くように置いた。ついで、切片の内表面
に、大腸菌を一晩37℃でトリプチケースソイブロスで
培養した菌液を200μl置き、密栓後、37°Cで1
8時間培養した。The section was washed with a 70% ethanol aqueous solution in a sterile environment, the ethanol was dried and distilled off, and then placed on the bottom of a sample bottle with the inner surface facing upward. Next, 200 μl of E. coli cultured in trypticase soy broth at 37°C overnight was placed on the inner surface of the section, and after sealing, the culture was incubated at 37°C for 1 hour.
It was cultured for 8 hours.
その後、サンプル瓶に0.1%の界面活性剤(Twee
n80、出社産業)を含む生理食塩水を加えて菌液を回
収し、コロニーカウント法により生存菌数を測定した。Then, add 0.1% surfactant (Twee) to the sample bottle.
Physiological saline containing n80 (Issha Sangyo) was added to collect the bacterial solution, and the number of viable bacteria was measured by colony counting method.
コントロールとして、菌液をサンプル瓶の底に直装置い
た以外は上記方法と同様の操作を行った。As a control, the same procedure as above was performed except that the bacterial solution was placed directly at the bottom of the sample bottle.
その結果1回収された菌数はコントロールの0.7%で
あった。As a result, the number of bacteria recovered was 0.7% of the control.
また、実施例1の導尿カテーテルを室温の水に1週間浸
漬したのち、乾燥し、ついで上記の方法と同じ方法によ
り、抗菌活性テストを行ったところ2回収された菌数は
コントロールの5.2%であった。In addition, the urinary catheter of Example 1 was immersed in water at room temperature for one week, dried, and then subjected to an antibacterial activity test using the same method as described above.The number of bacteria recovered was 2.5 times that of the control. It was 2%.
比較例1
上記A液と同じ組成でpHが10.0のアニオン系天然
ゴムラテックス100部に、硝酸銀水溶液(10重量%
)を攪拌上添加したところ、配合ラテックスは急激に粘
度を増し、小さな凝集が多数生成した。Comparative Example 1 To 100 parts of anionic natural rubber latex having the same composition as the above liquid A and having a pH of 10.0, a silver nitrate aqueous solution (10% by weight) was added.
) was added with stirring, the blended latex suddenly increased in viscosity and many small agglomerates were formed.
得られたコーティング液を用いて、実施例1と同様にし
て導尿カテーテルの製造を試みたが、ラテックスの粘度
の増加及び多数の凝集塊の生成により1表面性状の均一
な導尿カテーテルを安定して製造することができなかっ
た。Using the obtained coating liquid, an attempt was made to manufacture a urinary catheter in the same manner as in Example 1, but due to the increase in the viscosity of the latex and the formation of a large number of aggregates, it was difficult to make a urinary catheter with a uniform surface texture. could not be manufactured.
実施例2
硝酸銀水溶液(10重量%)10部に代えてブロチイン
銀水溶液(20重量%)30部を用いた以外は実施例1
と同様にして導尿カテーテルの連続生産を行ったところ
1力月後においても浸漬槽中のラテックスは凝集塊を生
じることなく、一定品質の導尿カテーテルを安定して製
造することができた。Example 2 Example 1 except that 30 parts of brothin silver aqueous solution (20 wt%) was used instead of 10 parts of silver nitrate aqueous solution (10 wt%).
When urinary catheters were continuously produced in the same manner as above, even after one month, the latex in the dipping tank did not form any agglomerates, and urinary catheters of constant quality could be stably produced.
得られた導尿カテーテルについて、実施例1と同じ方法
により、抗菌活性テストを行ったところ。The obtained urinary catheter was subjected to an antibacterial activity test using the same method as in Example 1.
回収された菌数はコントロールの2.3%であった。The number of bacteria recovered was 2.3% of the control.
実施例3
硝酸銀水溶液(10重量%)10部に代えてピクリン酸
銀水溶液(5重量%)10部を用いた以外は実施例1と
同様にして導尿カテーテルの連続生産を行ったところ1
力月後においても浸漬槽中のラテックスは凝集塊を生じ
ることなく、一定品質の導尿カテーテルを安定して製造
することができた。 得られた導尿カテーテルについて
、実施例1と同じ方法により、抗菌活性テストを行った
ところ1回収された菌数はコントロールの6.8%であ
った。Example 3 Continuous production of urinary catheters was carried out in the same manner as in Example 1 except that 10 parts of silver picrate aqueous solution (5 wt%) was used instead of 10 parts of silver nitrate aqueous solution (10 wt%).1
The latex in the soaking bath did not form any agglomerates even after the test, and urinary catheters of constant quality could be stably manufactured. The obtained urinary catheter was subjected to an antibacterial activity test using the same method as in Example 1, and the number of bacteria recovered was 6.8% of the control.
(発明の効果)
本発明によれば、特別な工夫や高度な技術を要すること
なく、カチオン系天然ゴム又はカチオン系合成ゴムラテ
ックスに水溶性銀化合物を配合したラテックス組成物を
通常の生産ラインに組み込むだけで、持続的な抗菌活性
を有する抗菌性成型品を工業的規模で安定して連続生産
でき、その工業的意義は極めて大きいものがある。(Effects of the Invention) According to the present invention, a latex composition in which a water-soluble silver compound is blended with a cationic natural rubber or a cationic synthetic rubber latex can be produced on a normal production line without requiring special devices or advanced techniques. Just by incorporating it, antibacterial molded products with continuous antibacterial activity can be stably and continuously produced on an industrial scale, and its industrial significance is extremely large.
本発明によれば1例えば、長期の使用過程においても持
続的な抗菌性を有する医療器用具、衛生用具2食品製造
用機器又は備品などの成型品を製造することができる。According to the present invention, it is possible to produce molded products such as 1. medical equipment, sanitary tools, 2. food manufacturing equipment or equipment, etc., which have antibacterial properties that last even during long-term use.
そのような成型品の具体例としては、導尿カテーテルを
はじめとするカテーテル類2手術用手袋及びその他手袋
類2手指サック、l’i′Ii乳瓶用乳首、病院におい
て患者が使うアイスバンク、蓄尿ハングなどのハング類
、給排液チューブ、スポンジなどがあげられる。これら
はその表面に抗菌剤が存在し、バクテリヤや真菌などか
らの感染を防止するうえで極めて効果的である。Specific examples of such molded products include catheters such as urinary catheters, surgical gloves and other gloves, hand cots, l'i'Ii milk bottle nipples, ice banks used by patients in hospitals, Examples include hangs such as urine storage hangs, fluid supply and drainage tubes, and sponges. These have antibacterial agents on their surfaces and are extremely effective in preventing infections from bacteria and fungi.
=18−=18-
Claims (3)
なるコーティング液を用い、コーティング法にて成型品
を製造するに際し、コーティング液としてカチオン系天
然ゴムラテックス又はカチオン系合成ゴムラテックスに
水溶性銀化合物を配合したラテックス組成物を用いるこ
とを特徴とする抗菌性成型品の製造方法。(1) When manufacturing molded products by the coating method using a coating liquid made of natural rubber latex or synthetic rubber latex, a water-soluble silver compound is blended with the cationic natural rubber latex or cationic synthetic rubber latex as the coating liquid. A method for producing an antibacterial molded article, characterized by using a latex composition.
1項記載の製造方法。(2) The manufacturing method according to claim 1, wherein the water-soluble silver compound is silver nitrate.
範囲第1項記載の製造方法。(3) The manufacturing method according to claim 1, wherein the water-soluble silver compound is protein silver.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62296755A JPH0622589B2 (en) | 1987-11-25 | 1987-11-25 | Method for manufacturing antibacterial molded products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62296755A JPH0622589B2 (en) | 1987-11-25 | 1987-11-25 | Method for manufacturing antibacterial molded products |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01136663A true JPH01136663A (en) | 1989-05-29 |
JPH0622589B2 JPH0622589B2 (en) | 1994-03-30 |
Family
ID=17837695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62296755A Expired - Lifetime JPH0622589B2 (en) | 1987-11-25 | 1987-11-25 | Method for manufacturing antibacterial molded products |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0622589B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191192B1 (en) | 1997-06-23 | 2001-02-20 | Toyo Boseki Kabushiki Kaisha | Antibacterial polymeric moldings |
-
1987
- 1987-11-25 JP JP62296755A patent/JPH0622589B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191192B1 (en) | 1997-06-23 | 2001-02-20 | Toyo Boseki Kabushiki Kaisha | Antibacterial polymeric moldings |
Also Published As
Publication number | Publication date |
---|---|
JPH0622589B2 (en) | 1994-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4902503A (en) | Antimicrobial latex composition | |
US4675347A (en) | Antimicrobial latex composition | |
JP3151665B2 (en) | Biopolymer / polyallylamine complex and method for producing the same | |
US4549897A (en) | Protein degraded pre-vulcanized natural rubber coated slow release fertilizers | |
JPH11509873A (en) | Latex composition and film formed therefrom | |
CN106589611A (en) | Mildew-proof antibacterial antiviral PPR pipeline and preparation method thereof | |
GB2555955A (en) | Antimicrobial rubber and processes for making the same | |
JPH01136663A (en) | Manufacture of antibacterial molded item | |
JPS59227824A (en) | Antibacterial latex composition | |
JPH01136662A (en) | Preparation of antibacterial urethral catheter | |
JPS6081232A (en) | Antibacterial latex composition | |
CN108752663B (en) | Preparation method of nano propolis loaded calcium carbonate hollow microsphere/natural latex antibacterial composite membrane | |
JP3589842B2 (en) | Molding method from mixture of pre-vulcanized natural rubber latex and water-soluble polymer and molded article thereof | |
JPH01138246A (en) | Antibacterial latex composition | |
JP3580071B2 (en) | Antimicrobial resin composition and antimicrobial resin molded article using the same | |
JPH0434414B2 (en) | ||
JPH0588900B2 (en) | ||
JPH0310342B2 (en) | ||
US20140171545A1 (en) | Antimicrobial fillers for plastics | |
JPS61145235A (en) | Antibacterial latex composition | |
JPH10279794A (en) | Antimicrobial resin composition and molded product using the same | |
JPH0376343B2 (en) | ||
CN115028908A (en) | Anti-allergy and antibacterial natural latex product and preparation method thereof | |
JP2017163865A (en) | Livestock teat pack material and mastitis prevention method of dairy livestock | |
Claramma et al. | Studies on prevulcanization of rubber latex with special reference to influence of storage and after treatments on properties of films |